Trial intelligence / Profile preview

Dopamine transporter in pharmacological treatment of cocaine dependence (modafinil vs placebo)

2007-006262-16Phase 3Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in cocaine use disorder (CUD) comparing Modiodal with Placebo (2 arms). Primary endpoint: DAT binding potential on PET. Started Mar 2009; status: active.

02

Drugs

modafinil
03

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on 2007-006262-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006262-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call